Literature DB >> 20123010

Regulation effects on abnormal glucose and lipid metabolism of TZQ-F, a new kind of Traditional Chinese Medicine.

Wang Tao1, Zhang Deqin, Li Yuhong, Liu Hong, Liu Zhanbiao, Zhao Chunfeng, Hu Limin, Gao Xiumei.   

Abstract

AIM OF THE STUDY: Based on the recipe of the traditional anti-diabetic formula TZQ, we developed TZQ-F, a new formula including 8 fractions isolated from Red Paeony root, Mulberry leaf, Lotus leaf, Danshen root and Hawthorn leaf with a good quality assurance. The study was aimed at fraction preparation and effects of the fractions on abnormal glucose and lipid metabolism.
MATERIALS AND METHODS: The active fractions were obtained by macroporous resin, ion-exchange resin and polyamide resin column chromatographies. HPLC analyses were used for quality control. In vitro mechanism study included DPPH radical scavenging, AGEs formation inhibition, alpha-glucosidase inhibition and lipase inhibition, and rats on high-fat diet were used for in vivo study.
RESULTS: In vitro mechanism study showed that among the 8 fractions, three of them had inhibition effects on intestinal disaccharase, three with inhibition effects on lipase, and five with effects of free radical scavenging. In vivo study showed that after 4 weeks of treatment, TZQ-F significantly decreased the levels of serum total cholesterol, TG, glucose, LDL-C and HDL-C in rats on high-fat diet. Consistent with the in vitro and in vivo results, histology study demonstrated that TZQ-F alleviated hepatic steatosis induced by high-fat diet.
CONCLUSIONS: TZQ-F possesses the potential regulation effects on abnormal glucose and lipid metabolism. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20123010     DOI: 10.1016/j.jep.2010.01.044

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  10 in total

Review 1.  Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease.

Authors:  Hui Dong; Fu-Er Lu; Li Zhao
Journal:  Chin J Integr Med       Date:  2012-02-05       Impact factor: 1.978

Review 2.  Herbal medicines and nonalcoholic fatty liver disease.

Authors:  Hong Yao; Yu-Jie Qiao; Ya-Li Zhao; Xu-Feng Tao; Li-Na Xu; Lian-Hong Yin; Yan Qi; Jin-Yong Peng
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

3.  Exploring the interaction between Salvia miltiorrhiza and α-glucosidase: insights from computational analysis and experimental studies.

Authors:  Hongjin Tang; Dongsheng Zhao; Zhenglian Xue
Journal:  RSC Adv       Date:  2018-07-09       Impact factor: 4.036

4.  Pioglitazone, extract of compound Danshen dripping pill, and quercetin ameliorate diabetic nephropathy in diabetic rats.

Authors:  P Chen; J Chen; Q Zheng; W Chen; Y Wang; X Xu
Journal:  J Endocrinol Invest       Date:  2012-11-27       Impact factor: 4.256

5.  Increasing effect of Tangzhiqing formula on IRS-1-dependent PI3K/AKT signaling in muscle.

Authors:  Jing Gao; Jian Li; Yating An; Xuefeng Liu; Qian Qian; Yanlin Wu; Yi Zhang; Tao Wang
Journal:  BMC Complement Altern Med       Date:  2014-06-21       Impact factor: 3.659

Review 6.  Polyphenolic profile and biological activity of Chinese hawthorn (Crataegus pinnatifida BUNGE) fruits.

Authors:  Tunde Jurikova; Jiri Sochor; Otakar Rop; Jiri Mlcek; Stefan Balla; Ladislav Szekeres; Vojtech Adam; Rene Kizek
Journal:  Molecules       Date:  2012-12-06       Impact factor: 4.411

7.  Comparison of the Effects of Acarbose and TZQ-F, a New Kind of Traditional Chinese Medicine to Treat Diabetes, Chinese Healthy Volunteers.

Authors:  Huang Yuhong; Fu Wenxu; Li Yanfen; Liu Yu; Li Ziqiang; Yang Liu; Liu Shirong; Sun Jinxia; Li Na; Wang Baohe; Gao Xiumei; Zhang Deqin
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-06       Impact factor: 2.629

Review 8.  Preclinical Models for Investigation of Herbal Medicines in Liver Diseases: Update and Perspective.

Authors:  Hor-Yue Tan; Serban San-Marina; Ning Wang; Ming Hong; Sha Li; Lei Li; Fan Cheung; Xiao-Yan Wen; Yibin Feng
Journal:  Evid Based Complement Alternat Med       Date:  2016-01-28       Impact factor: 2.629

9.  Metabolomics-Based Clinical Efficacy and Effect on the Endogenous Metabolites of Tangzhiqing Tablet, a Chinese Patent Medicine for Type 2 Diabetes Mellitus with Hypertriglyceridemia.

Authors:  Jia Liu; Ziqiang Li; Hua Liu; Xianhua Wang; Chunxiao Lv; Ruihua Wang; Deqin Zhang; Yan Li; Xi Du; Yanfen Li; Baohe Wang; Yuhong Huang
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-24       Impact factor: 2.629

10.  Altering the inhibitory kinetics and molecular conformation of maltase by Tangzhiqing (TZQ), a natural α-glucosidase inhibitor.

Authors:  Yanfen Li; Xiaomao Zhang; Ruihua Wang; Lu Han; Wei Huang; Hong Shi; Baohe Wang; Ziqiang Li; Shaolan Zou
Journal:  BMC Complement Med Ther       Date:  2020-11-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.